Tag: Palynziq

Palynziq is a groundbreaking medication designed to treat adults with phenylketonuria (PKU), a rare genetic disorder that prevents the body from properly metabolizing phenylalanine, an amino acid found in protein-containing foods. This innovative therapy works by providing a synthetic version of the enzyme phenylalanine ammonia lyase (PAL), which helps break down phenylalanine into harmless byproducts that can be easily excreted by the body.

Palynziq offers a new treatment option for individuals with PKU who have not responded well to traditional dietary restrictions or other therapies. By lowering phenylalanine levels in the blood, this medication can help reduce the risk of cognitive impairment, neurological symptoms, and other complications associated with PKU.

Clinical trials have shown that Palynziq can effectively lower blood phenylalanine levels in adults with PKU, leading to improvements in cognitive function, executive function, and overall quality of life. Patients who have started treatment with Palynziq have reported feeling more energetic, focused, and better able to manage their symptoms.

As with any medication, Palynziq may cause side effects such as injection site reactions, allergic reactions, or changes in blood pressure. It is important for patients to work closely with their healthcare providers to monitor their response to treatment and adjust their dosage as needed.

Overall, Palynziq represents a significant advancement in the treatment of PKU, offering hope for improved outcomes and quality of life for individuals living with this challenging condition. If you or a loved one has PKU and are seeking a new treatment option, speak with your healthcare provider to see if Palynziq may be right for you.

What is Palynziq?
Palynziq is an enzyme replacement therapy used to treat phenylketonuria (PKU) in adults.

How does Palynziq work?
Palynziq works by breaking down phenylalanine, an amino acid that accumulates in the body of individuals with PKU.

Who can take Palynziq?
Palynziq is approved for use in adults with PKU who have uncontrolled blood phenylalanine levels.

What are the common side effects of Palynziq?
Common side effects of Palynziq include injection site reactions, joint pain, and headache.

How is Palynziq administered?
Palynziq is administered as a subcutaneous injection once daily, gradually increasing the dose under medical supervision.